A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
NCT07598136
This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, mint, or non-tobacco/non-menthol/non-mint-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Smoking
- Tobacco
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- RAI Services Company
- Last updated on ClinicalTrials.gov
- June 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Sago Orlando · Maitland, FL
Georgia · 1
- Sago Atlanta · Atlanta, GA
Missouri · 1
- Sago St. Louis · St Louis, MO
North Carolina · 1
- L&E Raleigh · Raleigh, NC
Pennsylvania · 1
- Sago Philadelphia · Philadelphia, PA
Texas · 2
- Sago Dallas · Dallas, TX
- Sago Houston · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.